Figure S2. 8-br-cAMP increases PA103-induced caspase-1 activation in PMVECs in a dose-dependent manner. PMVECs were serum starved for 60 min. The 8-br-cAMP (panel A) and 8-br-cGMP (panel B) compounds were added to the culture medium 30 min prior to addition of FLICA reagent and PA103 (MOI 10:1). Saline-treated PMVEC monolayers served as negative controls. PMVECs were harvested at 180 min post-infection and analyzed for activated caspase-1 by flow cytometry. For all conditions n=3. For 8-br-cAMP in panel A, the (*) indicates a significant difference, P<0.0001 (One-way ANOVA with Bonferroni’s post-hoc analysis). For 8-br-cGMP in panel B, no differences were observed, P=0.9972 (One way ANOVA)
(A), and an MOI dose-response relationship 2 days after infection (B). Symbols : ▫, virulent strain ...
<p>PBMCs from CF patients (n = 6) and healthy controls (n = 6) were primed with LPS (10 ng/ml) for 5...
(B, D, F) Summary of results obtained from experiments as illustrated in A, C and D. Carelease is di...
Figure S1. Optimization of FLICA assay for detection of active caspase-1 in PMVECs. A) Optimal washi...
<p>BMP-2 (40 ng/ml) significantly increased caspases 3 (<b>A</b>), 8 (<b>B</b>), and 9 (<b>C</b>) ac...
<p>A) HMEC-1 cells were stimulated with 0.1% DMSO (no treatment) and/or with forskolin (25 mM), VEGF...
<p>hBMVEC were treated as indicated, and then fixed and immunostained for the cleaved active form of...
<p><b>A-B).</b> HEK293 cells were transfected with GPR3-HA WT and 4 hr later treated with 5 µM Bis I...
Rically. The activities of caspase 3 (A), 8 (B), 9 (C), and 1 (D) are presented. Data are mean ± SD ...
<p>(A) Heparinized blood was incubated with 0.3 pmol/mL of <i>Br-</i>LPS or PBS for 30 minutes and s...
<p>MPF hampers Cdc20-APC/C interaction. (<i>A</i>) Cdc25C-phospho-ser-287, cdc25C and cdk1-phospho-t...
<p>cAMP (A) and cGMP (B) levels (number of experiments = 12) (for all comparisons p<0.0001); C. pAkt...
<p>Caspase -3 activation was monitored <i>via</i> (A) flow cytometry; whereas PARP-1 was analyzed <i...
<p>10<sup>5</sup> freshly isolated buffy coat PMNs were stimulated for 9 hours with N-ac-PGP (10<sup...
<p>(A) The percentage of CD11c<sup>+</sup> BMDCs was analyzed by FACS. (B) BMDCs were incubated with...
(A), and an MOI dose-response relationship 2 days after infection (B). Symbols : ▫, virulent strain ...
<p>PBMCs from CF patients (n = 6) and healthy controls (n = 6) were primed with LPS (10 ng/ml) for 5...
(B, D, F) Summary of results obtained from experiments as illustrated in A, C and D. Carelease is di...
Figure S1. Optimization of FLICA assay for detection of active caspase-1 in PMVECs. A) Optimal washi...
<p>BMP-2 (40 ng/ml) significantly increased caspases 3 (<b>A</b>), 8 (<b>B</b>), and 9 (<b>C</b>) ac...
<p>A) HMEC-1 cells were stimulated with 0.1% DMSO (no treatment) and/or with forskolin (25 mM), VEGF...
<p>hBMVEC were treated as indicated, and then fixed and immunostained for the cleaved active form of...
<p><b>A-B).</b> HEK293 cells were transfected with GPR3-HA WT and 4 hr later treated with 5 µM Bis I...
Rically. The activities of caspase 3 (A), 8 (B), 9 (C), and 1 (D) are presented. Data are mean ± SD ...
<p>(A) Heparinized blood was incubated with 0.3 pmol/mL of <i>Br-</i>LPS or PBS for 30 minutes and s...
<p>MPF hampers Cdc20-APC/C interaction. (<i>A</i>) Cdc25C-phospho-ser-287, cdc25C and cdk1-phospho-t...
<p>cAMP (A) and cGMP (B) levels (number of experiments = 12) (for all comparisons p<0.0001); C. pAkt...
<p>Caspase -3 activation was monitored <i>via</i> (A) flow cytometry; whereas PARP-1 was analyzed <i...
<p>10<sup>5</sup> freshly isolated buffy coat PMNs were stimulated for 9 hours with N-ac-PGP (10<sup...
<p>(A) The percentage of CD11c<sup>+</sup> BMDCs was analyzed by FACS. (B) BMDCs were incubated with...
(A), and an MOI dose-response relationship 2 days after infection (B). Symbols : ▫, virulent strain ...
<p>PBMCs from CF patients (n = 6) and healthy controls (n = 6) were primed with LPS (10 ng/ml) for 5...
(B, D, F) Summary of results obtained from experiments as illustrated in A, C and D. Carelease is di...